Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04938700Phase 4Unknown
Phase 4, randomised trial in allergic rhinitis (AR), asthma, atopic dermatitis (AD) and 1 more (2 arms), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoints: The distribution and quantity of intestinal flora at 1 year, Total Nasal Symptom Score at 1 year and 4 more. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04938700.